Log In
Print
BCIQ
Print
Print this Print this
 

BNC375

  Manage Alerts
Collapse Summary General Information
Company Bionomics Ltd.
DescriptionPositive allosteric modulator (PAM) of nicotinic acetylcholine receptor alpha 7 (CHRNA7)
Molecular Target Nicotinic acetylcholine receptor alpha 7 (CHRNA7)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner Merck & Co. Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$526.0M

$20.0M

$506.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today